The Silence Around DPN: What They Don’t Teach You

The beauty industry has spent decades convincing us that aging is a problem to solve.

Entire product categories have been built around the fear of wrinkles. Billions of dollars are invested every year into retinoids, injectables, resurfacing treatments, lasers, peels, and anti-aging campaigns designed to delay, reverse, or conceal the visible signs of time. Research institutions, cosmetic companies, and professional education programs devote enormous resources to understanding how skin ages, how wrinkles form, and how to preserve a youthful appearance for as long as possible.

Yet when it comes to conditions that disproportionately affect people with melanin-rich skin, the silence is striking.

One of the clearest examples is Dermatosis Papulosa Nigra, more commonly known as DPN.

DPN is a benign skin condition characterized by small, dark papules that most commonly appear on the face, neck, chest, and upper back. The condition is especially prevalent among individuals of African descent and frequently appears in multiple members of the same family, suggesting a strong genetic component.

For millions of people around the world, DPN is not rare. It is not obscure. It is not unusual.

And yet, most esthetics students graduate without ever hearing its name. This educational gap has real consequences. Without awareness of DPN, practitioners may overlook important aspects of their clients' skin health, feel uncertain when faced with unfamiliar presentations, or miss opportunities to provide sensitive and informed care. This lack of knowledge can lead to miscommunication, reduced professional confidence, and diminished trust between practitioner and client, especially for those seeking care that truly understands their needs.

When I attended esthetics school, I was taught about wrinkles, acne, rosacea, melasma, psoriasis, photoaging, and countless other skin concerns. We studied Fitzpatrick classifications, inflammatory responses, skin cancers, and pigmentation disorders. We learned the names of ingredients, treatment protocols, and contraindications.

What we did not learn about was DPN.

The omission was so complete that one could easily conclude the condition did not exist.

That absence matters.

Education does not merely teach what is important. It also communicates what is considered worthy of attention. When a condition affecting millions of people with melanin-rich skin is omitted from textbooks, classrooms, and continuing education programs, the message becomes clear: certain skin experiences are deemed central to the profession, while others are peripheral.

This is not simply an educational oversight. It reflects whose skin has historically been prioritized in beauty, cosmetic science, and dermatological research.

The beauty industry spends billions of dollars each year researching and marketing anti-aging products. Entire scientific disciplines have emerged around wrinkle prevention and collagen preservation. Consumers are taught to fear every fine line, every crease, every visible sign of maturity.

Acne receives extensive research attention and commercial investment. Hyperpigmentation has become a major market category. Skin brightening products generate billions in annual revenue worldwide.

Yet when it comes to DPN, research remains remarkably limited.

Few large-scale studies exist. Few treatment innovations are developed specifically for melanin-rich populations. Few educational resources help practitioners understand the condition beyond basic removal techniques. For those interested in expanding their knowledge, organizations such as the Skin of Color Society, the American Academy of Dermatology, and continuing education platforms often provide specialized resources and webinars on DPN and related conditions. Seeking out reputable sources, scholarly articles, and expert-led training can empower practitioners to deepen their understanding and better serve diverse skin needs.

The disparity is difficult to ignore.

It raises an important question: What determines which skin concerns receive attention and which are left behind?

The answer is not biology alone.

The answer is often economics.

Conditions that affect populations with greater commercial influence tend to receive more funding, more research, and more visibility. Conditions that primarily affect marginalized populations often receive less attention, regardless of prevalence.

DPN exists at the intersection of this reality.

Because DPN is benign, it is frequently dismissed as purely cosmetic. Yet for many individuals, the emotional impact can be significant. People often become self-conscious about the appearance of lesions. They seek answers from practitioners who may never have been trained to recognize the condition. They are offered treatment recommendations that were not developed with melanin-rich skin in mind.

For practitioners, engaging in sensitive dialogue about DPN is an essential part of building trust. Acknowledge that DPN is common and reassure clients that their experiences are valid. Approach conversations with empathy by first asking open-ended questions about how clients feel about the condition, rather than making assumptions. Listen carefully and respect each client’s preferences regarding treatment or management. Use culturally aware language, avoiding stigmatizing terms, and demonstrate your understanding of how DPN may impact your client’s sense of self. When discussing options, be transparent about benefits, risks, and limitations, and always seek consent before any examination or recommendation. Ultimately, prioritize the client’s comfort and dignity throughout the interaction.

And this is where the conversation becomes particularly important.

For many people with melanin-rich skin, the greatest risk associated with DPN is not the lesion itself. It is the treatment.

Procedures that may be considered routine in lighter skin can produce unintended consequences in darker skin tones. Aggressive lasers, poorly selected energy devices, excessive cauterization, and inappropriate resurfacing techniques can trigger post-inflammatory hyperpigmentation, prolonged discoloration, textural changes, or even scarring. When considering DPN management in melanin-rich skin, safer and evidence-based approaches include gentle electrodessication by skilled practitioners, precise curettage, low-energy laser modalities such as long-pulsed Nd:YAG performed by experienced professionals, and topical options that support skin healing. Whenever possible, non-ablative and minimally invasive techniques are preferred, and thorough consultation should always be conducted to assess individual risks before proceeding. These methods offer a starting point for further research and support informed, safer practice.

In these situations, the treatment may create a greater cosmetic concern than the original lesion.

This is why Beautélanin™ approaches DPN differently.

We do not begin with removal.

We begin with understanding.

We begin by recognizing that melanin is not simply a pigment. It is an active biological participant in inflammation, wound healing, photoprotection, and skin adaptation. Any intervention involving melanin-rich skin must account for these realities.

This philosophy extends beyond procedures and into formulation science.

Many of the ingredients we prioritize are not intended to erase DPN. They are intended to support the skin environment surrounding it.

Ingredients such as beta-glucan help calm inflammation while supporting barrier recovery, and are often incorporated into calming serums or masks following procedures or as part of a daily routine. Ectoin is used in moisturizers and barrier creams to protect cellular integrity and reduce transepidermal water loss, making it suitable for post-procedure care or to support skin coping with environmental stressors. Niacinamide is commonly found in serums and creams designed for daily use, as it helps regulate inflammation and supports a more even skin appearance without increasing sensitivity. Pumpkin enzymes are often featured in gentle exfoliating masks or cleansers, providing mild resurfacing benefits once or twice per week. Colloidal oat and oat beta-glucan are included in soothing creams or masks to relieve irritation and reinforce the skin barrier, especially after treatments or during flare-ups. Saccharide isomerate is typically present in daily moisturizers, supporting long-term hydration and barrier resilience. Lipid-rich ingredients such as squalane, tamanu esters, and moringa esters are used in facial oils or creams to reduce friction and replenish protective lipids, making them ideal for barrier repair and daily maintenance. Bisabolol, allantoin, and panthenol are found in calming treatments and recovery balms, helping reduce redness and support the skin’s natural healing process after irritation or procedural interventions.

These ingredients are not miracle cures.

They are tools that respect the biology of melanin-rich skin.

And that distinction matters.

At Beautélanin™, we believe education begins by naming what has been ignored. DPN exists. It affects millions of people. It deserves recognition within professional education, research, and skincare conversations.

More importantly, the silence surrounding DPN reveals a larger truth.

When certain conditions are repeatedly omitted from textbooks, classrooms, and research agendas, the issue extends beyond a single diagnosis. It becomes evidence of a broader pattern in which melanin-rich skin is studied, discussed, and understood less.

The solution is not simply more treatments.

The solution is better questions.

Who is being represented?

Whose skin concerns are considered important?

Who benefits from the research being funded?

And whose experiences continue to remain invisible?

Because until those questions are asked, conditions like DPN will continue to exist in the margins—not because they are uncommon, but because the systems responsible for teaching skin have chosen not to see them.

At Beautélanin™, we choose to see them.